| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/18/2006 | CA2585421A1 Conjugates with enhanced cell uptake activity |
| 05/17/2006 | EP1657250A1 HLA-A *01-binding T-cell epitope of WT1 |
| 05/17/2006 | EP1656951A1 Conjugates with enhanced cell uptake activity |
| 05/17/2006 | EP1656946A1 Tissue adhesive using synthetic crosslinking |
| 05/17/2006 | EP1656390A2 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 05/17/2006 | EP1413174A4 Mounting arrangement for auxiliary burner or lance |
| 05/17/2006 | EP1387660A4 Use of 3-position cyclosporin derivatives for hair growth |
| 05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 05/17/2006 | EP1007729A4 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 05/17/2006 | EP0973391B1 Endoderm, cardiac and neural inducing factors |
| 05/17/2006 | EP0949333B1 Measles virus mutant antigen and gene encoding the same |
| 05/17/2006 | CN1774259A Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 05/16/2006 | US7045592 In situ chlorination, to generate amino acid chlorides, utilizing for solid phase peptide synthesis |
| 05/16/2006 | US7045591 Cyclic peptide for use in the treatment of eating disorders |
| 05/16/2006 | US7045504 Cyclic peptidomimetic urokinase receptor antagonists |
| 05/16/2006 | US7045503 Radiometal-binding peptide analogues |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045310 Measuring the concentration of preferential analyte in sample; obtain samples, incubate with binding particles, determine concentration of detectable particles |
| 05/16/2006 | US7045133 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/11/2006 | WO2006048556A1 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof |
| 05/11/2006 | WO2006048452A2 Peptides for use in treating of obesity |
| 05/11/2006 | WO2006048451A1 Peptides for use in the treatment of obesity |
| 05/11/2006 | WO2006048450A2 Peptides for use in the treating obesity |
| 05/11/2006 | WO2006048156A1 Cyclic nonapeptide amides |
| 05/11/2006 | WO2006048140A1 Methods for the specific production of lysobactin fragments |
| 05/11/2006 | WO2006034134A3 Antibacterial peptide with activity against b. anthracis |
| 05/11/2006 | WO2006017578A3 Peptide sequence for modulation of delta protein kinase c |
| 05/11/2006 | WO2005090389A3 Isosteric transformation |
| 05/11/2006 | WO2005072766A3 Peptides that bind to hsp90 proteins |
| 05/11/2006 | WO2005044313A3 Conjugates of angiotensin ii and an imaging moiety |
| 05/11/2006 | WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 05/11/2006 | US20060100156 Cell nucleus-entering compositions |
| 05/11/2006 | US20060100149 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 05/11/2006 | US20060100130 Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds |
| 05/11/2006 | US20060099571 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment |
| 05/11/2006 | US20060099275 Cell permeable peptides; inhibit NF-kB activation; inhibit anti-apoptotic processes in cancer cells to promote tumor cell death |
| 05/11/2006 | US20060099221 Method of screening anti-mycobacterial molecules |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/11/2006 | DE102004053410A1 Cyclische Nonadepsipeptidamide Cyclic Nonadepsipeptidamide |
| 05/11/2006 | DE102004053409A1 Verfahren zur gezielten Herstellung von Lysobactinfragmenten Method for the selective production of lysobactin fragments |
| 05/11/2006 | DE102004053407A1 Acylierte Nonadepsipeptide II Acylated nonadepsipeptides II |
| 05/11/2006 | CA2602070A1 Cyclic nonapeptide amides |
| 05/11/2006 | CA2586706A1 Methods for the specific production of lysobactin fragments |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1654280A2 Preparation of somatostatin peptides |
| 05/10/2006 | EP1653988A2 Leukocyte internalized peptide-drug conjugates |
| 05/10/2006 | EP1653986A2 Treatment of cancers expressing p95 erbb2 |
| 05/10/2006 | EP1495006A4 Inhibitors of glycinamide ribonucleotide transformylase |
| 05/10/2006 | EP1478383A4 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 05/10/2006 | EP1320609B1 Isolated peptides which bind to hla-c molecules and uses thereof |
| 05/10/2006 | EP0684843B1 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING OF INFLAMMATION |
| 05/10/2006 | CN1771329A The use of PDE4D in the screening for medicaments against atherosclerosis |
| 05/10/2006 | CN1255428C Template-fixed peptidomimetics with antimicrobial activity |
| 05/10/2006 | CN1255427C Method and composition for treating liver cell cancer |
| 05/10/2006 | CN1255426C Peptides for treatment of erectile dysfunction |
| 05/09/2006 | US7041790 Fibrinogen binding moieties |
| 05/09/2006 | US7041787 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
| 05/09/2006 | US7041786 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 05/09/2006 | US7041642 Fluorescent bombesin-like peptides |
| 05/09/2006 | US7041639 Depsipeptide and congeners thereof for use as immunosuppressants |
| 05/09/2006 | US7041637 Echinocandin/carbohydrate complexes |
| 05/09/2006 | US7041506 Fibronectins; fibroblast growth factors |
| 05/09/2006 | US7041442 peptides or derivatives of the 65 kD lower matrix phoshpoprotein of HCMV useful for determining whether subjects have been exposed to the virus and for determining the peptide-induced production of interferon- gamma and/or TNF- alpha in CD8+ T cells isolated from subjects |
| 05/04/2006 | WO2006047049A2 Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof |
| 05/04/2006 | WO2006046589A1 ADSORBENT ADSORBING ANTIBODY AGAINST β1 ADRENORECEPTOR |
| 05/04/2006 | WO2006046569A1 Neuronal differentiation promoting peptide |
| 05/04/2006 | WO2006045483A2 On-resin peptide cyclization |
| 05/04/2006 | WO2006002221A3 Fluorogenic enzyme assays and substrates for kinases and phosphatases |
| 05/04/2006 | WO2005123759A3 FGFR binding peptides |
| 05/04/2006 | WO2005118628A3 Nucleic acid molecules encoding plant cyclotide polypeptides and methods of use |
| 05/04/2006 | WO2005108416A3 Myosin light chain kinase inhibitors and their use |
| 05/04/2006 | WO2005048944A3 Activatable photodynamic therapy agents |
| 05/04/2006 | US20060094862 Specificity exchangers that redirect antibodies to a pathogen |
| 05/04/2006 | US20060094663 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| 05/04/2006 | US20060094661 NY-ESO-1 peptide analogs |
| 05/04/2006 | US20060094659 Peptides having sequences that substantially correspond to a specific region in N-terminal domain I of DBP can block DBP enhancement of C5a or C5a des Arg chemotactic activity; use thereof for the treatment C5a or C5a des Arg-mediated disorders such as immunoinflammatory disorders |
| 05/04/2006 | US20060094658 Method and compositions for the treatment of gastrointestinal disorders |
| 05/04/2006 | US20060094071 Method for enriching and tracking pathologic modified prions-proteins(prpsc) |
| 05/04/2006 | US20060093625 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and an orphanin polypeptide as a targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 05/04/2006 | US20060093596 Genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 05/04/2006 | DE102004051023A1 Desoxo-Nonadepsipeptide Deoxo-nonadepsipeptides |
| 05/04/2006 | CA2588098A1 On-resin peptide cyclization |
| 05/04/2006 | CA2582581A1 Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof |
| 05/03/2006 | EP1652918A2 Methods for detecting protein interactions using conformationally constrained peptides |
| 05/03/2006 | EP1652856A1 Stress proteins-derived peptides and method of use thereof |
| 05/03/2006 | EP1652855A1 Polypeptides having brain disposition activity and utilization of the same |
| 05/03/2006 | EP1651672A2 Cyclic cadherin analogues comprising the sequence hav for modulating the migration of vascular smooth muscle cells |
| 05/03/2006 | EP1651268A2 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa |
| 05/03/2006 | CN1768079A Polypeptide |
| 05/03/2006 | CN1765922A T superfamily conotoxin peptide |
| 05/03/2006 | CN1254484C Solid-phase synthesis process of octreotide acetate |
| 05/03/2006 | CN1254483C Fast peptide-synthesizing process in solution |
| 05/03/2006 | CN1254271C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/02/2006 | US7038037 Method for sequential support-bound synthesis of conjugated oligomeric compounds |
| 05/02/2006 | US7038010 Agents and methods for promoting bone growth |
| 05/02/2006 | US7037897 TRI-, TETRA-, and penta-peptides having antiangiogenic activity |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037890 For cancer therapy |
| 05/02/2006 | US7037691 A N-(3-(1-alkylimidazol-5-yl)-2-(protected amino)propionic acid)-terminated mono-, oligo- or polypeptide as catalysts for the regio-/enantioselective synthesis of cyclitol phosphates, particularly D-myo-inositol monophosphate libraries |